Studying the Neurobiological Mechanisms of Non-specific Chronic Low Back Pain and Chronic Insomnia: a Four-group Cross-sectional Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorVrije Universiteit Brussel

About this trial

This study is a part of a larger project aiming to evaluate the neurobiological mechanisms underlying the relationship between sleep and pain in people with non-specific chronic low back pain. Specifically, this study aims to evaluate the neurobiological mechanisms underlying the relationship between chronic sleep disturbances and pain sensitivity in people with non-specific chronic low back pain and chronic insomnia.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18-60 years old.

Ability to speak and understand the Dutch Language.

Body mass index <30.

No smoking or nicotine use.

Disqualifiers

Shift worker.

Use of blood thinners.

(History of) Substance dependence/abuse.

Chronic pain conditions (≥3 months) other than chronic low back pain.

Trial population

Participants across all study groups will be recruited from the broad area around Leuven, Belgium, via local flyers and social media. Participants with non-specific chronic low back pain and/or chronic insomnia will also be recruited from the pain and/or sleep center of UZ Leuven, Belgium, as well as via primary care units and patient support groups targeting people in the Leuven area. Participants will be recruited and stratified according to sex and age to enable matching to the primary group of interest (chronic low back pain and comorbid insomnia), and a majority of females (\~two thirds) will be recruited to better represent the sex-distribution within the population representative of this group.

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • Real-life monitoring, experimental pain testing, brain imaging, blood and stool sampling.

    Other intervention

    See detailed study description and outcome measures.

Treatment groups

80 Participants
are divided into 4 treatment groups
Group A: Pain-free with good sleep habits (healthy controls)1 intervention
Group B: Non-specific chronic low back pain with good sleep habits1 intervention
Group C: Pain-free with chronic insomnia1 intervention
Group D: Non-specific chronic low back pain with comorbid chronic insomnia1 intervention

Trial outcomes

Primary outcomes

1

Brain metabolite concentrations

Concentration of brain metabolites measured using single-voxel magnetic resonance spectroscopy in five regions of interest: (1) pregenual anterior cingulate cortex (midline); (2/3) right/left thalamus; (4/5) right/left anterior insula.

Time frame
Day 2

Secondary outcomes

1

Brain-tissue microstructure diffusivity

Diffusivity data (diffusion-weighted signal) from different microstructural compartments within the brain (intra-axonal space, extra-axonal space, and free water) measured using diffusion-weighted magnetic resonance imaging.

Time frame
Day 2
2

Functional brain responses to evoked low back pain

Blood-oxygen-level-dependent (BOLD) signal acquired during an evoked low back pain task performed during functional magnetic resonance imaging sequence.

Time frame
Day 2
3

Manual pressure pain detection thresholds (mPDT)

Gradually increasing pressure (1 kgf/sec) applied using a manual pressure algometer (FPX50, Wagner Instruments, USA) until the first sensation of discomfort (mPDT) is (self-)reported. The measurement is repeated three times across six body sites: (1/2) right/left m. erector spinae; (3/4) right/left m. extensor carpi radialis; (5/6) right/left m. gastrocnemius.

Time frame
Day 1
4

Computerized pressure pain detection thresholds (cPDT)

Gradually increasing pressure (1 kPa/sec) applied via a computer-controlled blood pressure cuff (Nocitech, Aalborg University, Denmark) around the calf (dominant leg) until a first sensation of discomfort (cPDT) is rated.

Time frame
Day 1

Other outcomes

1

Pre-scanning total sleep time

Polysomnography-derived total sleep time (i.e., min asleep from sleep onset to offset) from the night preceding the brain scanning.

Time frame
One night between Day 1 and 2
2

Pre-scanning sleep efficiency

Polysomnography-derived sleep efficiency from the night preceding the brain scanning.

Time frame
One night between Day 1 and 2
3

Self-reported (REDCap) mood state assessed via a short (32-item) version of the Profile of Mood States (POMS-32)

The POMS-32 is a short version of the original 65-item POMS questionnaire, which evaluates mood states across six dimensions: tension-anxiety, depression-dejection, anger-hostility, vigour-activity, fatigue-inertia, and confusion-bewilderment. Total scores for each subscale vary, with higher scores indicating greater intensity of the corresponding mood state.

Time frame
Day 2
4

Self-reported (REDCap) sleepiness assessed via the Karolinska Sleepiness Scale (KSS)

The KSS is a single-item questionnaire (i.e., scale) that measures subjective sleepiness at a specific moment in time. Scores range from 1 to 9, with higher scores indicating greater sleepiness.

Time frame
Day 2

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vrije Universiteit Brussel

Lead sponsor

Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)

Collaborator

Universitaire Ziekenhuizen KU Leuven

Collaborator